Acadia University Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2012
NCT02035878
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

bifidobacterium longum (1 trial)

lactobacillus helveticus (1 trial)

Drugs in Phase 2 Trials (1)

probiotic (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Hyperkinesis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3